Abstract
A study of the utilization of leukocyte-poor, washed red blood cells (LPWRBC) during an eight-year period demonstrates indications for use of this blood component. A significant decrease in the incidence of transfusion reactions was noted when LPWRBC were used. In addition, the decrease in cellular and metabolic waste products, as well as the decrease in plasma potassium, makes the product ideal for transfusion of newborns, for transfusion of patients with hyperkalemia, and for multiply transfused patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
